Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,286 public trials 1,280 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

NCT00978458

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States
View all 168 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

NCT05459844

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The First Afilliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
View all 23 locations
View Trial Details
Active, Not Recruiting

GammaTile and Stupp in Newly Diagnosed GBM

NCT05342883

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • HonorHeath Scottsdale Osborn Medical Center Scottsdale, Arizona, United States
  • Keck Medicine of USC Los Angeles, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Advent Health Orlando Orlando, Florida, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

NCT06551064

Conditions
Melanoma, Melanoma Stage III, Melanoma, Stage II, +11 more
Locations
  • Formycon Investigative Site Sarajevo, Bosnia and Herzegovina
  • Formycon Investigative Site Sofia, Bulgaria
  • Formycon Investigative Site Tartu, Estonia
  • Formycon Investigative Site Batumi, Georgia
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma

NCT04047251

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Dana Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib in Recurrent Glioblastoma

NCT02981940

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

NCT05585320

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +29 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

NCT05155254

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
View all 112 locations
View Trial Details

Related conditions